Landscapes / Companies
Chiesi Farmaceutici S.p.A. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 approved
1 in Phase 3
Drugs
10
in active trials · 41 in all
Trials
15 active
96 since 2021
Drugs10
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
On the market | 3 Jun 2027Phase 2 trial completes | |||
| Next date | 3 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | Asthma | ||||
| Open drug page | |||||
— |
Protalix |
Approved | Oct 2027Phase 2/3 trial completes | ||
| Next date | Oct 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Fabry Disease | ||||
| Open drug page | |||||
Leptin analog |
Approved | Feb 2028Phase 4 trial completes | |||
| Next date | Feb 2028 · Phase 4 trial completes | ||||
| Also tested for | Partial Lipodystrophy, Familial Partial Lipodystrophy | ||||
| Open drug page | |||||
— |
Approved in the EU | 13 Jun 2028Phase 4 trial completes | |||
| Next date | 13 Jun 2028 · Phase 4 trial completes | ||||
| Also tested for | Asthma | ||||
| Open drug page | |||||
— |
Approved | — | |||
| Also tested for | Epidermolysis Bullosa, Junctional Epidermolysis Bullosa and 8 more | ||||
| Open drug page | |||||
— |
Haisco Pharmaceutical Group |
Phase 3 | Apr 2030Phase 3 trial completes | ||
| Next date | Apr 2030 · Phase 3 trial completes | ||||
| Also tested for | Bronchiectasis | ||||
| Open drug page | |||||
— |
Phase 2 | 27 Jun 2028Phase 2 trial completes | |||
| Next date | 27 Jun 2028 · Phase 2 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis | ||||
| Open drug page | |||||
— |
Phase 1 | 28 Feb 2027Phase 1 trial completes | |||
| Next date | 28 Feb 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | Aug 2027Phase 1 trial completes | |||
| Next date | Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis | ||||
| Open drug page | |||||
— |
Phase 1 | 27 Dec 2027Phase 1 trial completes | |||
| Next date | 27 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Asthma | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 31 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021